Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Techniclone finalizes acquisition of Peregrine

June 5, 1997

Biomira notified of patent allowance for Theratope

May 30, 1997

AltaRex initiates U.S. phase IIb trial with Ovarex

May 28, 1997

Bexxar as first-line therapy for non-Hodgkin's lymphoma

May 26, 1997

Preliminary phase II and phase I/II results for Allovectin-7

May 22, 1997

Preliminary results indicate potential for AML treatment

May 21, 1997

Techniclone reports promising results from brain cancer treatment study

May 21, 1997

Somatix reports promising results from melanoma vaccine trials

May 21, 1997

Ribi theraccine available for licensing outside Canada

May 19, 1997

NIH announces prospective grant of exclusive license for IL-13 receptor-specific chimeric antibodies

May 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...